Chempartner Pharmatech Co., Ltd.

Chempartner Pharmatech Co., Ltd. is a prominent contract research organization (CRO) and contract development and manufacturing organization (CDMO) based in China, listed on the ChiNext board of the Shenzhen Stock Exchange since 2010. With a strong track record of 20 years in pharmaceutical research, ChemPartner provides a comprehensive range of integrated services that encompass drug discovery, development, and manufacturing. The company operates globally, with strategically located laboratories and business offices in the United States, Europe, and China. ChemPartner's main business lines include early drug discovery, preclinical research, and the development and manufacturing of both biologics and chemical drugs. The company has established a full-service, integrated R&D and manufacturing platform, offering end-to-end capabilities in biologics from discovery to large-scale production. ChemPartner is recognized for its innovation-driven approach, extensive service experience, and a high-performing team, which contribute to its competitive advantages in the pharmaceutical industry and a growing client base.

Throughout 20 years of operation, ChemPartner developed an integrated service platform covering early drug discovery, preclinical research and CDMO, including biologics and chemical drugs, and accumulated competitive advantages in terms of business model, core technology, innovation capability, customer base, project experience and talent team with several core competencies: 1. Full-service, integrated R&D and manufacturing platform covering both chemical and biological drugs; 2. End-to-end service capability and rich service experience in biologics, from discovery to large-scale production; 3. An innovation driven platform that offers efficient and comprehensive service solutions in preclinical drug development; 4. High-performing team of talents; 5. Expanding high-quality client base.